Semaglutide is a widely studied GLP-1 receptor agonist used for weight loss in Singapore
NovoCare self-pay program For members without weight-loss coverage, Novo Nordisk's NovoCare program offers approximately $199 per month for starting doses (first two fills through December 31, 2026), then approximately $349 per month for standard injection doses
Alcohol Use Disorder (AUD) AUD is a medical condition characterized by problematic drinking behaviors, such as: Consuming larger amounts over time Failed attempts to reduce intake Neglecting responsibilities due to alcohol Experiencing withdrawal symptoms A healthcare provider can provide a diagnosis and recommend treatment options
Convenient Locations and Scheduling We have offices in Riverview, Downtown Tampa, and North Tampaplus weekend and virtual availability
At CHC/Mens CHC, our medical providers do not prescribe Semorelin, Ipamorelin-CJC1295, or other type of growth hormone stimulating injectable unless you will be likely to experience benefits from this therapy and suffer from suboptimal growth hormone levels
